Leo I. Gordon, MD
Northwestern University · Robert H. Lurie Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Leo I. Gordon, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:28 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00532259 · CT-011 MAb in DLBCL Patients Following ASCTCureTech Ltd · completed · Lymphoma, Large Cell, Diffuse, Lymphoma, Mixed Cell, Diffuse, Primary Mediastinal Large B-Cell Lymphoma
- Ph1/Ph2NCT00089284 · Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHLNorthwestern University · terminated · Non-Hodgkin's Lymphoma (NHL) · principal investigator
- Ph2NCT00004169 · Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's DiseaseNorthwestern University · completed · Lymphoma · study chair
- Ph2NCT00002657 · SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantSWOG Cancer Research Network · completed · Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm · study chair
- Ph3NCT00004230 · Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell TransplantationNorthwestern University · completed · Cancer · study chair
- Ph2NCT00004171 · Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's LymphomaNorthwestern University · completed · Lymphoma · study chair
- Ph2NCT00070447 · Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell LymphomaNational Cancer Institute (NCI) · completed · Lymphoma · unknown
- Ph1/Ph2NCT00004916 · Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's LymphomaNorthwestern University · completed · Lymphoma · study chair
- Ph2NCT00004231 · Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell LymphomaNorthwestern University · completed · Lymphoma · study chair
- Ph1/Ph2NCT00004907 · Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's LymphomaNorthwestern University · completed · Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Southwest Oncology Group Treatment GrantU10CA032102 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHARLES D. BLANKE · fiscal years 1985 to 2013Named on NCT00002657
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.